Nov 24 (Reuters) - IX Biopharma Ltd IXBI.SI :
* ENTERED INTO AN EXCLUSIVE LICENSE AGREEMENT WITH SEELOS THERAPEUTICS
* WILL RECEIVE US$9 MILLION UPFRONT PAYMENT TO BE SATISFIED IN CASH AND SHARES
* ALSO ELIGIBLE FOR UP TO US$239 MILLION IN MILESTONE PAYMENTS AS PART OF DEAL
Source text for Eikon: ID:nSN4DNx5y Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))